ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 71 filers reported holding ALBIREO PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $406,000 | -18.8% | 20,300 | +31.0% | 0.07% | -21.7% |
| Q2 2019 | $500,000 | +8.9% | 15,500 | +8.8% | 0.09% | +9.5% |
| Q1 2019 | $459,000 | +54.5% | 14,250 | +17.8% | 0.08% | +35.5% |
| Q4 2018 | $297,000 | -31.2% | 12,100 | -7.6% | 0.06% | -17.3% |
| Q3 2018 | $432,000 | -9.2% | 13,100 | -2.2% | 0.08% | -12.8% |
| Q2 2018 | $476,000 | +44.7% | 13,400 | +32.7% | 0.09% | +38.7% |
| Q1 2018 | $329,000 | +36.5% | 10,100 | +7.4% | 0.06% | +37.8% |
| Q4 2017 | $241,000 | -24.2% | 9,400 | -38.2% | 0.04% | -27.4% |
| Q3 2017 | $318,000 | +1.6% | 15,200 | 0.0% | 0.06% | -4.6% |
| Q2 2017 | $313,000 | – | 15,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |